Bard Associates’s Biofrontera BFRIW Stock Holding History

Bard Associates’s Portfolio BFRIW Stock Details BFRIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.17K	Hold	154,900	–	–	﹤0.01%	267
2026 Q1	$5.92K	Hold	154,900	–	–	﹤0.01%	223
2025 Q4	$13.9K	Hold	154,900	–	–	﹤0.01%	201
2025 Q3	$15K	Hold	154,900	–	–	﹤0.01%	157
2025 Q2	$16.3K	Sell	154,900 -25,000	-14%	-$2.11K	0.01%	169
2025 Q1	$11K	Hold	179,900	–	–	﹤0.01%	175
2024 Q4	$10.9K	Hold	179,900	–	–	﹤0.01%	177
2024 Q3	$4.16K	Hold	179,900	–	–	﹤0.01%	173
2024 Q2	$6.32K	Sell	179,900 -4,000	-2%	-$204	﹤0.01%	168
2024 Q1	$12.4K	Sell	183,900 -4,000	-2%	-$118	﹤0.01%	173
2023 Q4	$1.88K	Sell	187,900 -13,000	-6%	-$324	﹤0.01%	172
2023 Q3	$6.05K	Sell	200,900 -100	-0%	-$9	﹤0.01%	183
2023 Q2	$22.1K	Hold	201,000	–	–	0.01%	180
2023 Q1	$49.2K	Hold	201,000	–	–	0.02%	180
2022 Q4	$40.4K	Hold	201,000	–	–	0.02%	185
2022 Q3	$71K	Hold	201,000	–	–	0.03%	175
2022 Q2	$143K	Buy	201,000 +5,000	+3%	+$5.51K	0.06%	164
2022 Q1	$286K	Sell	196,000 -14,100	-7%	-$19.6K	0.1%	151
2021 Q4	$756K	Buy	+210,100	New	+$453K	0.25%	116

Other funds holding BFRIW

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bard Associates's BFRIW Position: Q2 2026 in Review

Bard Associates held its Biofrontera (BFRIW) position steady in Q2 2026 at 154,900 shares worth $4.17K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Bard Associates first reported a position in BFRIW in Q4 2021 and has held it in 19 quarters since. The position peaked at $756K in Q4 2021. 5 funds tracked by Wall St. Rank hold BFRIW as of Q2 2026.

Bard Associates held 154,900 shares of Biofrontera worth $4.17K as of Q2 2026.
Bard Associates left its Biofrontera share count unchanged in Q2 2026.
Biofrontera made up ﹤0.01% of Bard Associates's portfolio in Q2 2026, its #267 holding.
Bard Associates first reported a position in Biofrontera in Q4 2021 and has held it in 19 quarters since.
Bard Associates's Biofrontera position peaked at $756K in Q4 2021.
5 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.